LINACBSCgalcisplatinmalignant cancersHNCcanine head and neck cancerPD-1 inhibitorsimmunotherapySABR
…d the efficiency of BSCgal under a clinical linear accelerator (LINAC) and explored the capability of BSCgal to treat canine head and…
Entity family
Universities, hospitals, research centres, networks, and public bodies. Examples include universities, NHS trusts, research networks.
This institution is selected. Its supporting articles are shown below.
…d the efficiency of BSCgal under a clinical linear accelerator (LINAC) and explored the capability of BSCgal to treat canine head and…